At the Rutgers American Parkinson Disease Association Center for Advanced Research —one of only nine such centers—we don’t just seek to treat the symptoms of Parkinson’s but to cure it. By focusing on ...

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

Psilocybin-assisted psychotherapy could lead to significant improvements in anxiety, pessimism, and disease acceptance among those with Parkinson’s disease, according to researchers from the ...

John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...

Tom Nolan reviews this week’s research Microplastics and nanoplastics (MNPs) are being found just about everywhere we look, and they have now been found in our brains. A report in Nature Medicine ...

Scientists from the University of Rochester and other research centers have found a strong link between a widely used ...

They hope these same drugs can restore waste disposal in the brains of older humans and help protect against brain diseases.

A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A recent study by Queen Mary University of London suggests that antiepileptic drugs may be linked to an increased risk of ...

Matthew Moore will bring his play “What I Didn’t Say — a Journey Through Parkinson’s” to Orlando. He wrote the play to “fight back.” ...

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.